SCHEMBL30689392

SCHEMBL30689392

C=C(Cc1nc(-c2ccc(Oc3cccc(C)n3)cc2)no1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.44
▸ ATM Q13315 1/20 0.44
▸ RAB9A P51151 3/20 0.43
▸ TSHR P16473 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ TP53 P04637 4/20 0.43
▸ GSTP1 P09211 3/20 0.43
▸ MITF O75030 1/20 0.43
▸ NCOA3 Q9Y6Q9 1/20 0.43
▸ ACACB O00763 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ FFAR1 O14842 1/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689323 0.87 TP53 (0.42) LMNAATMRAB9ATP53GSTP1
SCHEMBL30689449 0.87 LMNA (0.44) LMNAATMTSHRTP53GSTP1
SCHEMBL30689336 0.85 LMNA (0.43) LMNAATMTSHRTP53GSTP1
SCHEMBL30689383 0.85 TP53 (0.41) LMNAATMTP53GSTP1MITF
SCHEMBL30689347 0.84 IP6K1 (0.48) LMNAATMRAB9ATSHRTP53
SCHEMBL31527959 0.83 LMNA (0.42) LMNAATMRAB9ATSHRNFKB1
SCHEMBL30689424 0.81 TP53 (0.43) LMNAATMRAB9ATSHRNFKB1
SCHEMBL31527827 0.81 TP53 (0.46) LMNAATMRAB9ATP53GSTP1
SCHEMBL30689438 0.80 LMNA (0.51) LMNAATMRAB9ATSHRTP53
SCHEMBL31527955 0.80 LMNA (0.46) LMNAATMRAB9ATSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback